DRAXIS appoints new president

July 8, 2001

Richard Flanagan has been named president of DRAXIS’ radiopharmaceutical subsidiary, DRAXIMAGE. He has succeeded Ray Dore, who plans to retire in September but will continue to serve as a special advisor. Flanagan, who is currently executive vice

Richard Flanagan has been named president of DRAXIS’ radiopharmaceutical subsidiary, DRAXIMAGE. He has succeeded Ray Dore, who plans to retire in September but will continue to serve as a special advisor. Flanagan, who is currently executive vice president, has been with DRAXIMAGE since its founding in 1997.